BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32467618)

  • 1. An immunopathogenic perspective of interleukin-1 signaling.
    Lin X; Twelkmeyer T; Wang SY; Xu RN; Wang FS; Zhang C; Tang H
    Cell Mol Immunol; 2020 Aug; 17(8):892-893. PubMed ID: 32467618
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-36 Signaling Is Essential for Psoriatic Inflammation through the Augmentation of Innate Immune Responses.
    Ohko K; Nakajima K; Kataoka S; Takaishi M; Sano S
    J Invest Dermatol; 2019 Jun; 139(6):1400-1404. PubMed ID: 30571968
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-1 Signaling Mediates Obesity-Promoted Elevations in Inflammatory Cytokines, Wnt Activation, and Epithelial Proliferation in the Mouse Colon.
    Pfalzer AC; Crott JW; Koh GY; Smith DE; Garcia PE; Mason JB
    J Interferon Cytokine Res; 2018 Oct; 38(10):445-451. PubMed ID: 30328795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive interleukin-1 signaling determines the development of Th1 and Th17 responses in chronic inflammation.
    Joosten LA
    Arthritis Rheum; 2010 Feb; 62(2):320-2. PubMed ID: 20112403
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-1beta Inhibition Attenuates Vasculitis in a Mouse Model of Kawasaki Disease.
    Hashimoto Y; Fukazawa R; Nagi-Miura N; Ohno N; Suzuki N; Katsube Y; Kamisago M; Akao M; Watanabe M; Hashimoto K; Tsuno K; Matsui R; Itoh Y
    J Nippon Med Sch; 2019; 86(2):108-116. PubMed ID: 31130561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral interference with IL-1 and toll signaling.
    Janeway C; Medzhitov R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10682-3. PubMed ID: 11005852
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
    Ge Y; Huang M; Yao YM
    Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia.
    Stoffels B; Hupa KJ; Snoek SA; van Bree S; Stein K; Schwandt T; Vilz TO; Lysson M; Veer CV; Kummer MP; Hornung V; Kalff JC; de Jonge WJ; Wehner S
    Gastroenterology; 2014 Jan; 146(1):176-87.e1. PubMed ID: 24067878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interleukin-1 Family.
    Yazdi AS; Ghoreschi K
    Adv Exp Med Biol; 2016; 941():21-29. PubMed ID: 27734407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regnase-1, an Immunomodulator, Limits the IL-36/IL-36R Autostimulatory Loop in Keratinocytes to Suppress Skin Inflammation.
    Takaishi M; Satoh T; Akira S; Sano S
    J Invest Dermatol; 2018 Jun; 138(6):1439-1442. PubMed ID: 29339122
    [No Abstract]   [Full Text] [Related]  

  • 12. Biology of IL-36 Signaling and Its Role in Systemic Inflammatory Diseases.
    Yuan ZC; Xu WD; Liu XY; Liu XY; Huang AF; Su LC
    Front Immunol; 2019; 10():2532. PubMed ID: 31736959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term exposure to IL-1beta enhances Toll-IL-1 receptor-mediated inflammatory signaling in murine airway hyperresponsiveness.
    Zhang Y; Xu CB; Cardell LO
    Eur Cytokine Netw; 2009 Sep; 20(3):148-56. PubMed ID: 19825525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 Shunts Eicosanoid Metabolism to Repress CD14 Licensed Interleukin-1β Release and Inflammation.
    Zoccal KF; Gardinassi LG; Sorgi CA; Meirelles AFG; Bordon KCF; Glezer I; Cupo P; Matsuno AK; Bollela VR; Arantes EC; Guimarães FS; Faccioli LH
    Front Immunol; 2018; 9():890. PubMed ID: 29755470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.
    Lindemann S; Tolley ND; Dixon DA; McIntyre TM; Prescott SM; Zimmerman GA; Weyrich AS
    J Cell Biol; 2001 Aug; 154(3):485-90. PubMed ID: 11489912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1beta (IL-1beta) processing pathway.
    Weber A; Wasiliew P; Kracht M
    Sci Signal; 2010 Jan; 3(105):cm2. PubMed ID: 20086236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Disease and the NLRP3 Inflammasome.
    Kanneganti TD
    N Engl J Med; 2017 Aug; 377(7):694-696. PubMed ID: 28813221
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-1β influences functional regeneration following nerve injury in mice through nuclear factor-κB signaling pathway.
    Wu R; Chen B; Jia X; Qiu Y; Liu M; Huang C; Feng J; Wu Q
    Immunology; 2019 Mar; 156(3):235-248. PubMed ID: 30418673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures.
    Sun Y; Ma J; Li D; Li P; Zhou X; Li Y; He Z; Qin L; Liang L; Luo X
    J Neuroinflammation; 2019 Mar; 16(1):66. PubMed ID: 30922332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine Supports IL-1β Production in Macrophages Through mTOR Signaling.
    Chen S; Xia Y; He F; Fu J; Xin Z; Deng B; He L; Zhou X; Ren W
    Front Immunol; 2020; 11():1866. PubMed ID: 32973770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.